問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberCLAF237A2398
Not yet recruiting

2006-08-01 - 2008-02-01

Phase I

Terminated5

  • Trial Applicant

    NOVARTIS (TAIWAN) CO., LTD.

  • Sponsor

  • Trial scale

  • Update

    2026/03/01

Investigators and Locations

Principal Investigator 郭熙文

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hsieh Hsieh

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 周劍文

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Chwen-Tzuei Chang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    70 participants

  • Global

    850 participants